DISEASE INDICATIONS: Achondroplasia
MANUFACTURER: BioMarin Europe Ltd
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Voxzogo (vosoritide) is a prescription medicine used to increase linear growth in children with achondroplasia aged 5 years and older with open growth plates. Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.
